原发性颅内肿瘤的免疫生物学。II. 原发性脑肿瘤患者淋巴细胞亚群分析
Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours.
作者信息
Brooks W H, Roszman T L, Mahaley M S, Woosley R E
出版信息
Clin Exp Immunol. 1977 Jul;29(1):61-6.
Abstract
Circulating peripheral blood lymphocyte subpopulations were analysed in patients with primary intracranial neoplasia. Patients with tumours of glial origin demonstrated a significant depletion of E-rosetting lymphocytes whereas the quantitative lymphocyte profiles of patients with non-glial brain tumours were normal. The number of immunoglobulin and Fe receptor-bearing cells was not significantly altered in any group of patients: however, the EAC-RFC subpopulation was increased in those with malignant gliomas. Two hypotheses are suggested to explain these observations: first, the presence of cross-reacting antibody between T cells and brain (glial) cells, and secondly, the proliferation of EAC-RFC in response to malignant degeneration.
摘要
对原发性颅内肿瘤患者的循环外周血淋巴细胞亚群进行了分析。胶质源性肿瘤患者的E花环形成淋巴细胞显著减少，而非胶质脑肿瘤患者的淋巴细胞定量分布正常。任何一组患者中免疫球蛋白和带有铁受体的细胞数量均无显著改变：然而，恶性胶质瘤患者的EAC-RFC亚群增加。提出了两种假说以解释这些观察结果：第一，T细胞与脑（胶质）细胞之间存在交叉反应抗体；第二，EAC-RFC因恶性变性而增殖。
相似文献
1
2
3
4
In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.原发性胆汁性肝硬化和慢性肝炎中的体外细胞介导细胞毒性。原发性胆汁性肝硬化中自发细胞介导细胞毒性的功能障碍。
J Clin Invest. 1977 Nov;60(5):1116-28. doi: 10.1172/JCI108863.
5
T- and B-lymphocyte subpopulations in pre-invasive and invasive carcinoma of the cervix.宫颈原位癌及浸润癌中的T淋巴细胞和B淋巴细胞亚群
Clin Exp Immunol. 1977 Dec;30(3):421-8.
6
Loss of circulating T lymphocytes with normal levels of B and 'null' lymphocytes in Thai adults with malaria.泰国成年疟疾患者循环T淋巴细胞减少，而B淋巴细胞和“无标记”淋巴细胞水平正常。
Clin Exp Immunol. 1979 Feb;35(2):202-9.
7
Lymphocyte functions and subpopulation distribution in marmosets.狨猴的淋巴细胞功能及亚群分布
Primates Med. 1978;10:184-92.
8
T-lymphocyte subpopulations in rheumatoid arthritis.类风湿关节炎中的T淋巴细胞亚群
Z Rheumatol. 1980 Sep-Oct;39(9-10):348-55.
9
Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.原发性颅内肿瘤患者淋巴细胞激活受损的细胞动力学基础。
J Immunol. 1984 Mar;132(3):1208-15.
10
引用本文的文献
1
Within and beyond the tumor: Mechanisms of glioblastoma-induced immunosuppression.肿瘤内外：胶质母细胞瘤诱导免疫抑制的机制
Neurooncol Adv. 2025 Sep 9;7(Suppl 4):iv4-iv18. doi: 10.1093/noajnl/vdaf006. eCollection 2025 Sep.
2
Prior corticosteroid treatment alters cPBMC composition and IFNγ response to immunotherapy in canine cancer.先前的皮质类固醇治疗会改变犬类癌症中循环外周血单核细胞（cPBMC）的组成以及对免疫疗法的γ干扰素（IFNγ）反应。
Front Immunol. 2025 Apr 24;16:1544949. doi: 10.3389/fimmu.2025.1544949. eCollection 2025.
3
Biomarkers of immunotherapy in glioblastoma.胶质母细胞瘤免疫治疗的生物标志物
Neurooncol Pract. 2024 Apr 1;11(4):383-394. doi: 10.1093/nop/npae028. eCollection 2024 Aug.
4
Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege.全身免疫紊乱在各种中枢神经系统疾病中都存在，反映了免疫豁免的新机制。
Neurooncol Adv. 2023 Apr 11;5(1):vdad035. doi: 10.1093/noajnl/vdad035. eCollection 2023 Jan-Dec.
5
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications.恶性神经胶质瘤进展的多方面机制及其临床意义。
Cancer Metastasis Rev. 2022 Dec;41(4):871-898. doi: 10.1007/s10555-022-10051-5. Epub 2022 Aug 3.
6
Checkpoint: Inspecting the barriers in glioblastoma immunotherapies.检查点：检查胶质母细胞瘤免疫疗法中的障碍。
Semin Cancer Biol. 2022 Nov;86(Pt 3):473-481. doi: 10.1016/j.semcancer.2022.02.012. Epub 2022 Feb 10.
7
Immunotherapy Resistance in Glioblastoma.胶质母细胞瘤中的免疫治疗耐药性
Front Genet. 2021 Dec 17;12:750675. doi: 10.3389/fgene.2021.750675. eCollection 2021.
8
Genetic and molecular epidemiology of adult diffuse glioma.成人弥漫性神经胶质瘤的遗传和分子流行病学。
Nat Rev Neurol. 2019 Jul;15(7):405-417. doi: 10.1038/s41582-019-0220-2. Epub 2019 Jun 21.
9
Turning "Cold" Into "Hot" Tumors-Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers.将“冷”肿瘤转化为“热”肿瘤——原发性和转移性脑癌放射免疫治疗的机遇与挑战
Front Oncol. 2019 Mar 19;9:163. doi: 10.3389/fonc.2019.00163. eCollection 2019.
10
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.在脑胶质瘤和其他颅内肿瘤的情况下，T 细胞在骨髓中的隔离。
Nat Med. 2018 Sep;24(9):1459-1468. doi: 10.1038/s41591-018-0135-2. Epub 2018 Aug 13.
本文引用的文献
1
Is the brain an "immunologically privileged site"? 2. Studies in induced host resistance to transplantable mouse glioma following irradiation of prior implants.大脑是一个“免疫特权部位”吗？2. 对先前植入物进行照射后诱导宿主对可移植小鼠胶质瘤产生抗性的研究。
Arch Neurol. 1965 Sep;13(3):283-6. doi: 10.1001/archneur.1965.00470030063005.
2
Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors.人类恶性脑肿瘤中的毛细血管超微结构与血脑屏障
J Neurosurg. 1970 Feb;32(2):127-44. doi: 10.3171/jns.1970.32.2.0127.
3
Demonstration of a complement of inactivator on cultured cells from human malignant brain tumours.人恶性脑肿瘤培养细胞中灭活剂补体的证明。
Acta Neurol Scand. 1974;50(6):681-9. doi: 10.1111/j.1600-0404.1974.tb02814.x.
4
Enumeration of absolute numbers of T and B lymphocytes in human blood.人体血液中T淋巴细胞和B淋巴细胞绝对数量的计数
Scand J Immunol. 1974;3(2):161-72. doi: 10.1111/j.1365-3083.1974.tb01244.x.
5
Human lymphocytes with receptors for IgG. A population of cells distinct from T- and B-lymphocytes.带有IgG受体的人类淋巴细胞。一群与T淋巴细胞和B淋巴细胞不同的细胞。
Int Arch Allergy Appl Immunol. 1974;47(1):124-38. doi: 10.1159/000231207.
6
Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines.人类白血病细胞和人类淋巴母细胞系上补体和免疫球蛋白的受体
J Clin Invest. 1972 Aug;51(8):1933-8. doi: 10.1172/JCI106999.
7
Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells.脑相关θ抗原：兔抗小鼠脑与小鼠淋巴细胞的反应性。
Cell Immunol. 1971 Aug;2(4):353-61. doi: 10.1016/0008-8749(71)90070-0.
8
Immune responses in patients with gliomas.胶质瘤患者的免疫反应。
Surg Neurol. 1974 Nov;2(6):419-23.
9
Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.原发性颅内肿瘤患者细胞介导免疫功能低下。一种体液免疫抑制因子的特性。
J Exp Med. 1972 Dec 1;136(6):1631-47. doi: 10.1084/jem.136.6.1631.
Zotero 插件